Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Biolinerx Ltd

+1 (972) 254-8910
Website

Advertisement

Advertisement

15400 Calhoun Dr Ste 125
Derwood, MD 20855
+1 (972) 254-8910
https://ir.biolinerx.com

Biolinerx Ltd is a biotechnology company based in Derwood, MD, specializing in innovative research and development within the life sciences sector.

They focus on creating cutting-edge solutions and products to address pressing challenges in healthcare and the environment, utilizing advanced technologies and scientific expertise.

Generated from their business information

Also at this address

Claude C Lapp Architect

Health Spire

Offit Kurman Yumkas & Denick

Amerikor Title

Own this business?
Claim it
See a problem?

You might also like

Business services, nec, nec, Industrial and labor consulting services, Drugs affecting neoplasms and endrocrine systems

Northwest Biotherapeutics, Inc

Northwest Biotherapeutics is a biotechnology company that focuses on the clinical development of autologous immunotherapy products for cancer. The company s technology platform, DCVax, uses a patient s own dendritic cells. These cells are the starter engines of the immune system, which are loaded with tumor proteins or antigens. Injection of dendritic cells back into the patient initiates a potent immune response against cancer cells, resulting in delayed time to progression and prolonged survival. The company s two lead product candidates, DCVax-Prostate and DCVax-Brain, are in Food & Drug Administration-allowed late stage clinical trials, from which licensure is possible. Related products in the company s pipeline are also ready to enter Phase I clinical trials. Northwest Biotherapeutics is located in Bothell, Wash.
Art and architectural supplies, Business services, nec, nec, Services, nec, nec

Rise Therapeutics

Rise Therapeutics, LLC is a biopharmaceutical company located in Rockville, MD, dedicated to developing groundbreaking medicines through strategic partnerships with academic, biotechnology, and pharmaceutical organizations. With a focus on innovation and commitment, Rise Therapeutics aims to revolutionize the healthcare industry by creating novel therapies that address unmet medical needs.Generated from the website
Drugs affecting neoplasms and endrocrine systems, Drugs and drug proprietaries, Biological research

GlycoMimetics

GlycoMimetics develops novel small molecule therapeutics based upon the roles that carbohydrates play in biological processes. The company believes that carbohydrate mimics, or glycomimetic compounds, represent a new class of drugs. It has identified some compounds with potential therapeutic utility. One class has potential in the treatment of infectious diseases with a novel mechanism of action; the second is a class of anti-inflammatory compounds that have been shown to reduce key measures of inflammation. One of GMI s lead opportunities is to treat or prevent infections caused by Pseudomonas aeruginosa. Its objective in this program is to develop a drug that would be used in conjunction with antibiotics against chronic infections that have failed to respond to antibiotic treatment. The company also has compounds that inhibit selectin binding. Its initial focus in this program is to develop a product to treat acute exacerbations of asthma and chronic obstructive pulmonary disease. GlycoMimetics is headquartered in Gaithersburg, Md.
United States›Maryland›Derwood›Biolinerx Ltd

Partial Data by Infogroup (c) 2024. All rights reserved.

Partial Data by Foursquare.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell